Literature DB >> 1987255

Progression of cognitive impairment in Alzheimer's disease.

A Burns1, R Jacoby, R Levy.   

Abstract

Change in cognitive function was assessed over 12 months in 110 patients over the age of 65 satisfying National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS/ADRDA) criteria for "probable" Alzheimer's Disease. A highly significant deterioration in cognitive function was observed. Decline in cognitive scores was relatively normally distributed. Patients who died during the follow-up had more apraxia at entry to the study than survivors. A greater rate of decline was seen in patients whose parents suffered from dementia (but not in those where a sibling or other relative was affected), in subjects who had moderate dementia, and those who had been ill for less than 24 months. Age, age of onset, and the presence or absence of aphasia or apraxia had no influence on rate of progression. A cluster analysis revealed three patterns of decline.

Entities:  

Mesh:

Year:  1991        PMID: 1987255     DOI: 10.1111/j.1532-5415.1991.tb05904.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  9 in total

1.  Risk Factors for Progression of Alzheimer Disease in a Canadian Population: The Canadian Outcomes Study in Dementia (COSID).

Authors:  Nathan Herrmann; Tetsuhiro Harimoto; Robert Balshaw; Krista L Lanctôt
Journal:  Can J Psychiatry       Date:  2015-04       Impact factor: 4.356

2.  Associations of cumulative Pb exposure and longitudinal changes in Mini-Mental Status Exam scores, global cognition and domains of cognition: The VA Normative Aging Study.

Authors:  Zishaan Farooqui; Kelly M Bakulski; Melinda C Power; Marc G Weisskopf; David Sparrow; Avron Spiro; Pantel S Vokonas; Linda H Nie; Howard Hu; Sung Kyun Park
Journal:  Environ Res       Date:  2016-10-19       Impact factor: 6.498

3.  Factors affecting the age of onset and rate of progression of Alzheimer's disease.

Authors:  J V Bowler; D G Munoz; H Merskey; V Hachinski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-08       Impact factor: 10.154

4.  Dementia and subnormal levels of vitamin B12: effects of replacement therapy on dementia.

Authors:  S Teunisse; A E Bollen; W A van Gool; G J Walstra
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

5.  The Progression of Alzheimer's Disease: Are Fast Decliners Really Fast? A Four-Year Follow-Up.

Authors:  Federica Barocco; Marco Spallazzi; Letizia Concari; Simona Gardini; Annalisa Pelosi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

6.  Cerebral Perfusion Changes after Acetyl-L-Carnitine Treatment in Early Alzheimer's Disease Using Single Photon Emission Computed Tomography.

Authors:  Hyeonseok S Jeong; Jong-Sik Park; YoungSoon Yang; Seung-Hee Na; Yong-An Chung; In-Uk Song
Journal:  Dement Neurocogn Disord       Date:  2017-03-31

7.  Changes in Regional Cerebral Perfusion after Nicergoline Treatment in Early Alzheimer's Disease: A Pilot Study.

Authors:  Jooyeon J Im; Hyeonseok S Jeong; Jong-Sik Park; YoungSoon Yang; Seung-Hee Na; Jin Kyoung Oh; Yong-An Chung; In-Uk Song
Journal:  Dement Neurocogn Disord       Date:  2017-12-31

8.  AD Course Map charts Alzheimer's disease progression.

Authors:  Igor Koval; Alexandre Bône; Maxime Louis; Thomas Lartigue; Simona Bottani; Arnaud Marcoux; Jorge Samper-González; Ninon Burgos; Benjamin Charlier; Anne Bertrand; Stéphane Epelbaum; Olivier Colliot; Stéphanie Allassonnière; Stanley Durrleman
Journal:  Sci Rep       Date:  2021-04-13       Impact factor: 4.379

9.  Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.

Authors:  Carina Wattmo; Åsa K Wallin
Journal:  Alzheimers Res Ther       Date:  2017-08-31       Impact factor: 6.982

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.